top of page

An entrepreneur describes launching a cell therapy startup in Houston

March Biosciences’ Co-Founder & CEO Sarah Hein on the infrastructure available in Houston for biotech startups, and the science behind her company’s CD5 CAR-T.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page